Yu Horibe

ORCID: 0000-0003-0343-5731 · 6 papers in corpus
observational 2026
·doi:10.21203/rs.3.rs-10865216/v1

Abstract Background. Endometriosis and adenomyosis are both oestrogen-dependent and both are treated with progestins, yet response to progestin therapy is not uniform. Progesterone resistance is usually described as a property of endometri…

case-report 2025
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2024.12.014

OBJECTIVE: Urinary tract endometriosis affects 0.3-12 % of all cases of endometriosis. Medications have limited efficacy in treating advanced disease. Serous cystadenofibroma is a rare benign variant of ovarian epithelial tumors comprising …

other 2025
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit-d-25-00031
case-report 2025
Cureus ·doi:10.7759/cureus.94394

Reports of Mesonephric-like adenocarcinoma (MLA) arising from other than the ovary and uterus are exceedingly rare. This report details two cases of MLA in patients with a history of endometriosis. One of these two cases is believed to be t…

observational 2022
Middle East Fertility Society journal ·doi:10.1186/s43043-022-00112-8

PURPOSE: In Tokyo, where the highest coronavirus disease 2019 (COVID-19) infection rates have been reported nationally, we introduced and performed polymerase chain reaction (PCR) testing on the patients prior to them coming for oocyte retr…

2018